Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
Gene Tests Identify Breast Cancer Patients Who Can Skip Chemotherapy, Study Says
By Denise Grady
When is it safe for a woman with breast cancer to skip chemotherapy? A new study helps answer that question, based on a test of gene activity in tumors. It found that nearly half of women with early-stage breast cancer who would traditionally receive chemo can avoid it, with little risk of the cancer coming back or spreading in the next five years.
This isn't new. I was given the Oncotype test back in 2008 to see if I needed chemo for my small, Stage 1 breast tumor.
Unfortunately, my score was in the "middle" range (33 or 34, I forget exactly), and so it became a judgement call. I chose to go ahead with the chemo because of my young age (39). It has been almost eight years now and the tumor did not come back or spread. Of course I don't know if it wouldn't have come back anyway, but it was not a chance I wanted to take with those results.
Had the Oncotype DX test after my bi-lateral mastectomy in 2011. My score was a 7 so I chose not to do chemo and I'm still here.
Please register to post and access all features of our very popular forum. It is free and quick. Over $68,000 in prizes has already been given out to active posters on our forum. Additional giveaways are planned.
Detailed information about all U.S. cities, counties, and zip codes on our site: City-data.com.